Biomarin Pharmaceutical

BMRNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$12.333 B

$63.81 +3.82%

Close of 7 Aug 2026

Revenue

$3.22B

#873 by revenue

Earnings

$348.9M

#769 by earnings

Shares outstanding

193,573,759

Latest filing cover page

P/E ratio

35.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#27Ascendis Pharma A/SASND$15.8B
#28Arrowhead PharmaceuticalsARWR$12.4B
#29Biomarin PharmaceuticalBMRN$12.3B
#30Corcept TherapeuticsCORT$12.0B
#31Madrigal PharmaceuticalsMDGL$11.8B

Where these numbers come from

Share counts and financials for Biomarin Pharmaceutical are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.